The person in charge of the laboratory is surprised by the spread of the disease

Orders for monkeypox vaccines have soared at the Danish laboratory Bavarian Nordic, the only one that manufactures an already approved vaccine against the disease. However, those responsible are convinced that they will be able to respond to requests.

“The approval [das autoridades de saúde norte-americanas] received in 2019 (…) has suddenly become very, very relevant for international health,” said Rolf Sass Sørensen, vice president of the company, at the port of Copenhagen, the laboratory’s headquarters.

Surprised by the spread of the disease outside the 11 African countries where it was endemic, Sass Sørensen said they would be able to fulfill the requests despite having only one production plant.

“With the current demand we can easily supply the world market. We have a few million doses in bulk, we can put them in vials and ensure that the current epidemic is treated”, explains the vice president of the laboratory to AFP.

Bavarian Nordic has an annual production capacity of 30 million doses at its factory in the north of the Danish capital. Their smallpox vaccine is third generation and is a live vaccine that does not replicate in the human body.

Leave a Reply